Wender: Mammography Guidelines Should Balance Benefits and Risks, Not Costs

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

A controversial study on the costs of unnecessary mammography, published in the April issue of Health Affairs, contains “serious methodological flaws,” said Richard Wender, chief cancer control officer at the American Cancer Society.

To access this subscriber-only content please log in or renew your subscription.

Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.

Login Subscribe

YOU MAY BE INTERESTED IN

U.S. Deputy Secretary for Health and Human Services, Andrea Palm, and Sweden's Minister for Health Care, Acko Ankarberg Johansson, signing the agreement. Credit: Joel Apelthun/Government Offices of SwedenThe United States and Sweden signed an agreement to step up collaborations in science and technology by focusing on cancer research.
Matthew Bin Han Ong
Senior Editor

Login